Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage topoisomerase ii'

Search results for: 'research area dna damage topoisomerase ii'

Items 21-30 of 48

Page
per page
  1. Mechlorethamine HCl
    B1785 Mechlorethamine HCl
    Summary: DNA synthesis inhibitor
  2. (-)-Blebbistatin
    B1387 (-)-Blebbistatin
     3 Citation
    Target: Myosin II ATPases
    Summary: Non muscle myosin II ATPase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥14.62 mg/mL
  3. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    Target: Topoisomerases
    Summary: Topoisomerase 1 inhibitor
      ≥23.1 mg/mL
  4. MC1568
    A4094 MC1568
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Class II HDAC inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥15.7 mg/mL
  5. Valsartan
    B2214 Valsartan
    Target: Angiotensin AT1 Receptors
    Summary: Angiotensin II AT1 receptor antagonist
  6. Azilsartan
    B2210 Azilsartan
    Target: Angiotensin AT1 Receptors
    Summary: Potent angiotensin II type 1 (AT1) receptor inverse agonist
      insoluble in EtOH; insoluble in H2O; ≥16.95 mg/mL
  7. Fostriecin sodium salt
    A4536 Fostriecin sodium salt
    Target: PP1|PP2A|Topoisomerases|PP4
    Summary: Antitumor antibiotic
      Soluble in H2O
  8. UAMC 00039 dihydrochloride
    B5780 UAMC 00039 dihydrochloride
    Target: Dipeptidyl-peptidase II
    Summary: dipeptidyl peptidase II (DPP-II) inhibitor
      ≥133.6 mg/mL
  9. GlyH-101
    B1087 GlyH-101
    Target: CFTR
    Summary: CFTR Inhibitor II
      insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL
  10. FT-207 (NSC 148958)
    B1474 FT-207 (NSC 148958)
    Summary: DNA/RNA synthesis inhibitor
      ≥100 mg/mL

Items 21-30 of 48

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 45item
  2. Natural Products 1 item
Reversibility
  1. Reversible 4item
  2. Irreversible 1 item
Target
  1. Caspases 1 item
  2. Cyclin-Dependent Kinases 1 item
  3. Histone Deacetylases (HDACs) 2item
  4. Akt 1 item
  5. PI3K 2item
  6. mTOR 2item
  7. AP-1 1 item
  8. Myosin II ATPases 1 item
  9. Thymidylate Synthase 1 item
  10. Pim 2item
  11. Voltage-gated Sodium (NaV) Channels 1 item
  12. PP1 1 item
  13. PP2A 1 item
  14. MET 1 item
  15. STAT 2item
  16. JAK 1 item
  17. DNA-PK 3item
  18. Angiotensin AT2 Receptors 2item
  19. CFTR 1 item
  20. Topoisomerases 6item
  21. DNA Methyltransferases 1 item
  22. Ca2 /calmodulin-dependent protein kinases (CaMKs) 3item
  23. USP 1 item
  24. ATM/ATR 2item
  25. CK2 1 item
  26. HIPK2 1 item
  27. HIPK3 1 item
  28. HIV Integrases 1 item
  29. P2X Receptors 1 item
  30. Carbonic Anhydrases 1 item
  31. BLM 1 item
  32. Synthases/Synthetases 2item
  33. MAGL 1 item
  34. RNA Polymerases 1 item
  35. CMV 1 item
  36. Angiotensin AT1 Receptors 2item
  37. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  38. Cytidine deaminases 1 item
  39. PP4 1 item
  40. Dipeptidyl-peptidase II 1 item
  41. HCV polymerase 1 item
  42. ATM 1 item
  43. Sirtuin 1 item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 1 item
  3. Acute Renal Failure 1 item
  4. Adrenocortical Carcinoma 1 item
  5. Bladder Cancer 2item
  6. Bladder Carcinoma 2item
  7. Bladder Diseases 1 item
  8. Breast Cancer 9item
  9. Cancer 30item
  10. Cervical Cancer 1 item
  11. Cholangiocarcinoma 1 item
  12. Colon Cancer 4item
  13. Colorectal Cancer 4item
  14. Diabetes 1 item
  15. Glioblastoma 1 item
  16. Glioma 1 item
  17. Hepatitis C 1 item
  18. Hepatocellular Carcinoma 1 item
  19. HIV Infections 1 item
  20. Inflammatory Diseases 1 item
  21. Leukemia 2item
  22. Lung Cancer 1 item
  23. Lymphoma 4item
  24. Melanoma 4item
  25. Multiple Myeloma 1 item
  26. Myeloma 1 item
  27. Ovarian Cancer 5item
  28. Pancreatic Cancer 3item
  29. Prostate Cancer 4item
  30. Renal Cell Carcinoma 1 item
  31. Sarcoma 1 item
  32. Squamous Cell Carcinoma 1 item
  33. Type 2 Diabetes 1 item